Atara Biotherapeutics
In Seth Klarman's portfolio · Baupost Group
Ticker ATRA
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2023 | Sell | 0 | |
| Q3 2023 | No change | 9,773,616 | 0.3% |
| Q2 2023 | Add 7% | 9,773,616 | 0.3% |
| Q1 2023 | Add 12% | 9,123,616 | 0.5% |
| Q4 2022 | No change | 8,123,616 | 0.4% |
| Q3 2022 | No change | 8,123,616 | 0.5% |
| Q2 2022 | No change | 8,123,616 | 0.9% |
| Q1 2022 | Reduce 4% | 8,123,616 | 0.8% |
| Q4 2021 | No change | 8,477,488 | 1.3% |
| Q3 2021 | No change | 8,477,488 | 1.4% |
| Q2 2021 | No change | 8,477,488 | 1.1% |
| Q1 2021 | Reduce 7% | 8,477,488 | 1.0% |
| Q4 2020 | Reduce 8% | 9,108,988 | 1.7% |
| Q3 2020 | No change | 9,922,030 | 1.4% |
| Q2 2020 | Add 19% | 9,922,030 | 1.8% |
| Q1 2020 | No change | 8,308,900 | 1.0% |
| Q4 2019 | No change | 8,308,900 | 1.5% |
| Q3 2019 | Add 19% | 8,308,900 | 1.3% |
| Q2 2019 | Add 10% | 7,000,000 | 1.3% |
| Q1 2019 | Add 2% | 6,380,519 | 2.1% |
| Q4 2018 | No change | 6,254,632 | 1.9% |
| Q3 2018 | No change | 6,254,632 | 2.0% |
| Q2 2018 | No change | 6,254,632 | 2.0% |
| Q1 2018 | Add 17% | 6,254,632 | 2.4% |
| Q4 2017 | No change | 5,359,632 | 1.0% |
| Q3 2017 | No change | 5,359,632 | 1.1% |
| Q2 2017 | No change | 5,359,632 | 0.9% |
| Q1 2017 | No change | 5,359,632 | 1.3% |
| Q4 2016 | No change | 5,359,632 | 1.0% |
| Q3 2016 | No change | 5,359,632 | 1.6% |
| Q2 2016 | No change | 5,359,632 | 1.6% |
| Q1 2016 | No change | 5,359,632 | 1.5% |
| Q4 2015 | No change | 5,359,632 | 2.6% |
| Q3 2015 | Add 11% | 5,359,632 | 2.8% |
| Q2 2015 | Add 1% | 4,809,632 | 4.2% |
| Q1 2015 | Add 91% | 4,763,265 | 3.2% |
| Q4 2014 | Buy | 2,495,913 | 1.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.